Stock Events

Stock Events

Search...

Nektar Therapeutics (NKTR) Q2 2024 Earnings

9MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.45

-0.36

-0.28

-0.19

Details

Expected EPS

-0.19

Actual EPS

-0.19

Surprise EPS

0

Surprise Percent

+0%

Description

Nektar Therapeutics (NKTR) has reported earnings of -0.19 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.